Global Biopharmaceutical Company - Bristol Myers Squibb
2022 was an important year for our company, with significant clinical and regulatory achievements that broadened our portfolio, advanced our pipeline and, importantly, delivered innovative new medicines to patients. To learn more, and to view important cautionary statements about forward-looking information, read our 2022 Annual Report.
The future of diversity in clinical trials >
Meet some of the first cohort of diverse medical students dedicated to improving health equity who have been chosen to participate in the Robert A. Winn Clinical Investigator Pathway Program.
Cancer care milestone reached in Lesotho >
A cancer patient has received the first chemo infusion ever given within the country of Lesotho, in part, because of the work of the Bristol Myers Squibb Foundation. Read more about their global impact on access to cancer treatment.
Meet Mary Jean >
Mary Jean lives with a type of hereditary heart condition known as hypertrophic cardiomyopathy (HCM), that often keeps her from doing the things she loves. Hear her inspirational story and learn what motivates her resilience.
Bristol Myers Squibb is addressing patients' needs by exploring new approaches in multiple myeloma treatment and continuing research to further improve outcomes.
Bristol Myers Squibb continues to advance research to unlock the full potential of BCMA-targeted therapies across approaches in an effort to bring new options to patients living with multiple myeloma.
Bristol Myers Squibb is continuing to examine the immune system from multiple perspectives in order to find complementary combinations of therapies that have the potential to improve outcomes for patients.
Global Patient Week
Now in its eighth year, Global Patient Week is an essential part of our culture — it unifies us and reignites our passion to do more for our patients. As the first biopharma to set aside time solely focused on the individuals we are working for each and every day, Global Patient Week is a pinnacle of our year-round vision to transform patients’ lives through science.
Severyne lives with a chronic cancer. While she knows her cancer may return, she chooses hope over fear. She looks to the positive side of her journey — meeting new people, receiving promising treatment options and cherishing the sweet moments in her life. Hear what keeps her hopeful as she navigates life with this disease.
2021 GLOBAL INCLUSION & DIVERSITY
Leading with our Value of Inclusion
Moving forward. Together.
Emmy award winner Sterling K. Brown explores what it means to live with cancer in a series of conversations with survivors from across the country.
We’re looking for people who want to change lives. Join us as we transform patients’ lives through science.
Learn more about how we strive to produce sustained strong performance and shareholder value.
Looking for answers?
Quick links to helpful resources.
What we are talking about on Twitter
Our company’s legacy of innovation began in the early 1800s, when our founders made it their mission to bring better health solutions to patients who needed them most. Today, we are continuing that tradition by using the latest science and technology to help improve lives through the research and development of new medicines for serious diseases.